I-Mab to Present at 24th Annual Needham Virtual Healthcare Conference

ROCKVILLE, Md., March 26, 2025 (GLOBE NEWSWIRE) -- I-Mab (NASDAQ: IMAB), a US-based, global biotech company, focused on the development of precision immuno-oncology agents for the treatment of cancer, today announced that I-Mab’s management team will participate in 24th Annual Needham Virtual Healthcare Conference, being held April 7-10, 2025.

Details are as follows:

24th Annual Needham Virtual Healthcare Conference
Conference Date:	April 7-10, 2025
Format:	Company Presentation and one-on-one meetings
Presentation Time:	Monday, April 7, 2025, 8:45 to 9:25 AM ET
Webcast Link:	Register here

About I-Mab

I-Mab (NASDAQ: IMAB) is a US-based, global biotech company, focused on the development of precision immuno-oncology agents for the treatment of cancer. I-Mab has established operations in Rockville, Maryland, and Short Hills, New Jersey. For more information, please visit us at: https://www.i-mabbiopharma.com/ and follow us on LinkedIn and X.

I-Mab Investor & Media Contacts
PJ Kelleher
LifeSci Advisors
+1 617-430-7579
[email protected]
[email protected]

Source: I-Mab Biopharma

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Farmers & Merchants Bancorp (FMCB) Announces Increase in Quarterly Dividend
• Journey Announces Disposition of Assets
• Abraham, Fruchter & Twersky, LLP, Notifies Shareholders of a Class Action Lawsuit on Behalf of Investors who Acquired Shares of GPGI, Inc. (NYSE:GPGI) f/k/a CompoSecure, Inc. (NYSE:CMPO)